Endurant Capital Management LP Axonics, Inc. Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$49.38 - $63.75 $1.23 Million - $1.59 Million
24,871 New
24,871 $1.55 Million
Q4 2019

Feb 14, 2020
SELL
$19.57 - $28.96 $543,243 - $803,900
-27,759 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$26.92 - $42.41 $747,272 - $1.18 Million
27,759 New
27,759 $747,000

Others Institutions Holding AXNX

# of Institutions
221
Shares Held
42M
Call Options Held
83.4K
Put Options Held
65.3K
View Full List

About Axonics, Inc.

AXNX Quotes by TradingView
  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email